These investigations could help in the characterization of pharmacological drugs prompting the cancer cell sensitivity to lipid hydroperoxides generated by ionizing radiation (i.e., glutathione peroxidase 4 (GPX4) inhibitors) and, therefore, better define or reduce the patient’s exposure to ionizing radiation that can also damage non-tumoral tissues. This evidence concerns the gene GPX4 and cancer.